A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 16 charts
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
Phase 2 Terminated
3 enrolled 12 charts
BRIDGE
Phase 2 Terminated
10 enrolled
Pembro+Chemo in Brain Mets
Phase 2 Terminated
3 enrolled 7 charts
CARMEN-LC05
Phase 2 Terminated
57 enrolled 26 charts
Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
25 enrolled
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
265 enrolled 8 charts
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
1 enrolled 4 charts
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
Phase 2 Terminated
4 enrolled 9 charts
A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
Phase 2 Terminated
5 enrolled
Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer
Phase 2 Terminated
10 enrolled 10 charts
Phalcis
Phase 2 Terminated
57 enrolled 18 charts
A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy
Phase 2 Terminated
12 enrolled 3 charts
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
153 enrolled 13 charts
Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer
Phase 2 Terminated
93 enrolled
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
Phase 2 Terminated
3 enrolled 8 charts
Genetic Predictors of Benefit to Pembrolizumab
Phase 2 Terminated
19 enrolled 12 charts
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
Phase 2 Terminated
1 enrolled 10 charts
KN046 in Patients With Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
120 enrolled
Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
30 enrolled 28 charts
KEAPSAKE
Phase 2 Terminated
40 enrolled
Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients
Phase 2 Terminated
108 enrolled
Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer
Phase 2 Terminated
17 enrolled 8 charts
Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
Phase 2 Terminated
3 enrolled 11 charts
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Phase 2 Terminated
5 enrolled 6 charts
Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer
Phase 2 Terminated
7 enrolled 5 charts
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Terminated
39 enrolled 9 charts
Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC
Phase 2 Terminated
37 enrolled
Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo
Phase 2 Terminated
35 enrolled 14 charts
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
Phase 2 Terminated
9 enrolled 4 charts
2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer
Phase 2 Terminated
13 enrolled 13 charts
ARTEMIS
Phase 2 Terminated
124 enrolled 10 charts
S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Phase 2 Terminated
1 enrolled
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Phase 2 Terminated
66 enrolled 17 charts
The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab
Phase 2 Terminated
20 enrolled
An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
Phase 2 Terminated
59 enrolled 9 charts
Trans-MARBLE
Phase 2 Terminated
4 enrolled
GSK1120212 Rollover Study
Phase 2 Terminated
159 enrolled 9 charts
Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC
Phase 2 Terminated
23 enrolled 11 charts
Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
17 enrolled 10 charts
Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
Phase 2 Terminated
55 enrolled
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Phase 2 Terminated
76 enrolled 13 charts
Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer
Phase 2 Terminated
1 enrolled 5 charts
HighTySy
Phase 2 Terminated
2 enrolled
MARBLE
Phase 2 Terminated
4 enrolled
NRR
Phase 2 Terminated
10 enrolled 14 charts
Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer
Phase 2 Terminated
1 enrolled 3 charts
LCCC1407
Phase 2 Terminated
1 enrolled 5 charts
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Phase 2 Terminated
6 enrolled